Todd is a Partner at aMoon and has over 15 years of healthcare investment experience. Prior to joining aMoon, he was a Managing Director at Signet Healthcare Partners, a NYC-based investment fund that provides growth capital to commercial stage life-science companies. Todd has served on the boards of Arbor Pharmaceuticals (Sold to KKR), Apicore (Sold to Medicure), Impopharma, and Smart Medical Systems. He also helped oversee the investment in Claris Lifesciences (sold to Baxter).
Prior to joining Signet, Todd was an Investment Director at Joddes Limited, a family investment holding company with interests in a number of healthcare companies, including Pharmascience, Paladin Labs, Medicom, and Oral Science. He was previously a large-cap pharmaceutical analyst at Morgan Stanley. He started his career at Mercer Management Consulting serving clients across North America in the transportation and healthcare industries.
Todd received a B.Com (with High Distinction) from the University of Toronto and an MBA from The Wharton School at the University of Pennsylvania with concentrations in healthcare management and finance.